We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Pemphigoid bullosus jako nežádoucí účinek nových antidiabetik.
- Authors
Pochmanová, Petra
- Abstract
Association between the development of bullous pemphigoid and the use of some medicinal products, such as diuretics (spironolactone, furosemide) or some neuroleptics, is well documented in the literature. New oral diabetes drugs of glyptin type or inhibitors of dipeptidylpeptidase have expended this spectrum in recent years. Since 2018, 4 patiens with bullous dermatosis have been hospitalized in our dermatology department while taking linagliptin. This article aims to draw the attention of medical community to a possible increased incidence of bullous pemphigoid among diabetics patients who are treated with gliptins.
- Publication
Dermatologie Pro Praxi, 2021, Vol 15, Issue 2, p98
- ISSN
1802-2960
- Publication type
Article
- DOI
10.36290/der.2021.019